Product

Rifampicin-Resistant Mycobacterium tuberculosis Negative Control (Inactivated Pellet)

Product

Allplex™ MTB/MDR/XDRe Detection

Product

Allplex™ MTB/MDRe Detection

Product

Rifampicin-Resistant Mycobacterium tuberculosis Positive Control Panel (Inactivated Pellet)

Article

Clinical Utility of Cartridge-Based Nucleic Acid Amplification Test for Tuberculosis and Rifampicin Resistance Detection in the Vindhya Region of India: A Retrospective Study.

Research record from Cureus, 2026-08-13. PMID 42732277.

Article

Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings.

Research record from Arch Bronconeumol, 2026-04-24. PMID 42135169.

Article

Implementation of next-generation sequencing to guide care and public health action in settings with high burden of rifampicin-resistant tuberculosis: 32 stakeholder consensus statements generated using Delphi principles.

Research record from BMJ Public Health, 2026-10-05. PMID 42852055.

Article

Molecular Evaluation of Rifampicin and Isoniazid Resistance in Pulmonary Tuberculosis Using Cartridge-Based Nucleic Acid Amplification Test and Line Probe Assay.

Research record from Cureus, 2026-06-04. PMID 42403861.

Indicators

MTB DNA

Direct molecular detection of Mycobacterium tuberculosis complex in respiratory specimens.

Tests

Mycobacterium tuberculosis DNA Detection

Molecular detection of M. tuberculosis complex, with or without rifampicin resistance markers.

Article

Potentials and challenges of next generation sequencing-guided individualized treatment for management of rifampicin-resistant tuberculosis - A qualitative study.

Research record from PLoS One, 2026-06-26. PMID 42360998.

Article

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Research record from Nat Commun, 2026-06-11. PMID 42270607.